Who owns ACHIEVE LIFE SCIENCES INC?
- Ticker: ACHV
- CUSIP Number: 004468500
Tip: Access positions for across all investors
Analyze quarterly positions in Achieve Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Achieve Life Sciences stock
Who bought or sold ACHIEVE LIFE SCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 6.0M | $17M | 100% | Mar 2024 |
|
| Propel Bio Management | 2.5M | $11M | 100% | Mar 2024 |
|
| Sofinnova Ventures | 1.5M | $6.9M | 100% | Mar 2024 |
|
| Vanguard Group | 948k | $4.3M | 57% | Mar 2024 |
|
| ADAR1 Capital Management | 875k | $4.0M | 100% | Mar 2024 |
|
| Altium Capital Management | 836k | $3.8M | 100% | Mar 2024 |
|
| Nantahala Capital Management | 654k | $3.0M | 100% | Mar 2024 |
|
| CVI Holdings | 567k | $2.6M | 100% | Mar 2024 |
|
| Alyeska Investment Group | 471k | $2.1M | 100% | Mar 2024 |
|
| Shay Capital | 450k | $2.0M | -38% | Mar 2024 |
|
| Long Focus Capital Management | 248k | $1.1M | 0% | Mar 2024 |
|
| Susquehanna International | 237k | $1.1M | 489% | Mar 2024 |
|
| Simplify Asset Management | 218k | $990k | 100% | Mar 2024 |
|
| Geode Capital Management | 207k | $940k | 12% | Mar 2024 |
|
| Millennium Management | 194k | $880k | 100% | Mar 2024 |
|
| LPL Financial | 183k | $830k | 11% | Mar 2024 |
|
| Raymond James & Associates | 152k | $690k | -2% | Mar 2024 |
|
| Northern Trust | 99k | $449k | 25% | Mar 2024 |
|
| Wells Fargo & Company | 69k | $313k | -2% | Mar 2024 |
|
| BlackRock | 52k | $238k | 0% | Mar 2024 |
|
| Citadel Advisors | 36k | $162k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 28k | $126k | 100% | Mar 2024 |
|
| J. Goldman & Co | 25k | $112k | -64% | Mar 2024 |
|
| Bank of America Corporation | 22k | $102k | 242% | Mar 2024 |
|
| Goldman Sachs Group | 22k | $101k | 100% | Mar 2024 |
|
| Manchester Financial | 19k | $87k | 0% | Mar 2024 |
|
| Leucadia National Corporation | 12k | $52k | 100% | Mar 2024 |
|
| Madison Park Capital Advisors | 10k | $46k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 9.9k | $45k | -84% | Mar 2024 |
|
| Group One Trading | 6.6k | $30k | -35% | Mar 2024 |
|
| Qube Research & Technologies | 4.0k | $18k | 402800% | Mar 2024 |
|
| Tower Research Capital | 3.1k | $14k | -13% | Mar 2024 |
|
| Stephens Consulting | 3.0k | $14k | 0% | Mar 2024 |
|
| Brian McDonald | 2.5k | $11k | -55% | Mar 2024 |
|
| Cornerstone Planning Group | 100.00 | $474.000000 | 100% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 5.00 | $23.000000 | 100% | Mar 2024 |
|
| UBS Group | 2.00 | $9.000000 | 0% | Mar 2024 |
|
Who sold out of Achieve Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Walleye Trading Advisors | Dec 2023 | 84k | $344k |
| Diametric Capital | Sep 2023 | 79k | $341k |
| Springbok Capital Management | Sep 2023 | 25k | $109k |
| Squarepoint Ops | Dec 2023 | 23k | $95k |
| Simplex Trading | Dec 2023 | 12k | $47k |
| Bank of New York Mellon | Dec 2023 | 11k | $47k |
| Morgan Stanley | Sep 2023 | 2.2k | $9.5k |
| Godsey and Gibb | Dec 2023 | 453.00 | $1.9k |